Clinica Baviera(DE:D9Z)
€51.80-1.40 (-0.77%)
DE:D9Z
Clinica Baviera stock forecast
€51.80
At close:-1.40 (-0.77%)
Clinica Baviera (D9Z) Stock Forecast & Price Target
0 Followers
D9Z Analyst Ratings
Moderate Buy
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Clinica Baviera in the past 3 months
D9Z Stock 12 Month Forecast
Average Price Target
€71.50▲(38.03% Upside)Based on 1 Wall Street analysts offering 12 month price targets for Clinica Baviera in the last 3 months. The average price target is EUR 71.50 with a high forecast of EUR 71.50 and a low forecast of EUR 71.50. The average price target represents a 38.03% change from the last price of EUR 51.80.
Past 12 Months12 Month ForecastJan2026Oct2026
High€71.50
Average€71.50
Low€71.50
Highest Price TargetHighest€71.50Average Price Target€71.50Lowest Price TargetLowest€71.50
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
D9Z Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 1 | 1 | 1 | 0 |
In the current month, D9Z has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. D9Z average Analyst price target in the past 3 months is 71.50.
D9Z Financial Forecast
Consensus€0.00
D9Z Sales Forecast
Next quarter’s sales forecast for D9Z is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 82.96M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
D9Z Stock Forecast FAQ
What is DE:D9Z’s average 12-month price target, according to analysts?
Based on analyst ratings, Clinica Baviera’s 12-month average price target is €71.50.
What is DE:D9Z’s upside potential, based on the analysts’ average price target?
Clinica Baviera has 38.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Clinica Baviera a Buy, Sell or Hold?
Clinica Baviera has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Clinica Baviera’s share price target?
The average share price target for Clinica Baviera is €71.50. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €71.50, and the lowest forecast is €71.50. The average share price target represents a 38.03% increase from the current price of €51.8.
What do analysts say about Clinica Baviera?
Clinica Baviera’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Clinica Baviera?
To buy shares of DE:D9Z, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
